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Purpose: To investigate whether intraluminal thermometry provides sufficient information to apply high quality deep hyperther-
mia in pelvic tumors. 
Patients and Methods: The intratumor and intraluminal temperatures of 48 patients were analyzed per cancer type: rectum (21 
male, 14 female), cervix (n = 8), and bladder (n = 5). Temperature-dose parameters were calculated, temperature curves within 
each treatment session were compared, and correlation between intratumor and intraluminal temperatures was analyzed. 
Results: Intratumor and intraluminal temperatures at the same time points during individual treatments were highly correlated 
(mean correlation coefficient: 0.93). However, the quantitative level differed from 0.1 to 1.1 °C and the differences of the time-
temperature graphs varied per tumor group. Average intratumor and intraluminal temperatures were not different in the four 
groups. Intratumor thermometry was found not superior over intraluminal thermometry to improve tumor temperature level and 
homogeneity by SAR steering. 
Conclusion: Intraluminal thermometry provides sufficient information to apply deep hyperthermia to individual patients with 
centrally located rectum, cervix or bladder cancer. 
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Vergleich von intratumoralen und intraluminalen Temperaturen während lokoregionaler tiefer Hyperthermie 
von Beckentumoren 
Ziel: Es wurde untersucht, ob die intraluminale Thermometrie genug Informationen für die Anwendung einer qualitativ hochwer-
tigen regionalen Hyperthermie bei Beckentumoren liefert. 
Patienten und Methodik: Die intratumoralen und intraluminalen Temperaturen von 48 Patienten wurden nach Krebsart analy-
siert: Rektum (21 Männer, 14 Frauen), Gebärmutterhals (n = 8) und Blase (n = 5). Temperatur-Dosis-Parameter wurden berechnet, 
die Temperaturkurven im Rahmen jeder Behandlung wurden verglichen, und die Korrelation zwischen intratumoralen und intralu-
minalen Temperaturen wurde analysiert. 
Ergebnisse: Intratumorale und intraluminale Temperaturen zu denselben Zeitpunkten während individueller Behandlungen 
zeigten eine hohe Korrelation (mittlerer Korrelationskoeffizient 0,93). Die absoluten Temperaturen differierten jedoch von 0,1 bis 
1,1 °C, und die Unterschiede in den Zeit-Temperatur-Diagrammen waren tumorgruppenspezifisch. Die mittleren intratumoralen 
und intraluminalen Temperaturen waren in den vier Gruppen nicht unterschiedlich. Bezüglich einer Verbesserung der Tumortem-
peratur und der Homogenität fand sich keine Überlegenheit der intratumoralen Thermometrie gegenüber der intraluminalen 
Thermometrie. 
Schlussfolgerung: Die intraluminale Thermometrie liefert genug Informationen zur Anwendung der regionalen Hyperthermie bei 
individuellen Patienten mit zentral lokalisierten Rektum-, Gebärmutterhals- oder Blasenkarzinomen. 
Schlüsselwörter:  Hyperthermie · Rektum · Gebärmutterhals · Blase · Intratumor-/intraluminale Thermometrie 
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Introduction 
In the recent decades, multimodality treatment approaches 
for deep-seated pelvic malignancies including surgery, radio-
therapy, chemotherapy, and hyperthermia have become in-
creasingly sophisticated [2, 6, 9, 14]. When patients with deep 
seated tumors are under treatment, hyperthermia groups ap-
ply intratumor and/or intraluminal thermometry for tempera-
ture data acquisition. Strong variation exists in the opinions 
whether intratumor thermometry provides superior informa-
tion over intraluminal thermometry. Sneed et al. [7] state that 
intratumor thermometry is critically important, while van der 
Zee et al. [11] and Wust et al. [16] suggest, if intraluminal ther-
mometry is available, intratumor thermometry is neither an 
important requirement for prevention of toxicity, nor neces-
sary for SAR (specific absorption rate) steering. 
Van der Zee et al. [11] focused on the complications and 
clinical limitations of intratumor thermometry during deep 
hyperthermia of pelvic tumors and present a very limited ther-
mal analysis. Wust et al. [16] demonstrated that intraluminal 
measurements, specifically for cervical and rectal cancers, are 
suitable for estimating feasibility and effectiveness, and that 
there is no need for intratumor thermometry. 
The present study is an extension of that by van der Zee 
et al. [11]. It provides a rigorous analysis of temperature data, 
acquired both intratumorally and intraluminally, of patients 
with pelvic tumors, making it an independent replicate of 
the study by Wust et al. [16]. Questions were: (1) Is there a 
positive correlation between intratumor and intraluminal 
temperatures? (2) What are the quantitative/qualitative dif-
ferences between intratumor and intraluminal temperatures? 
(3) Can intratumor temperature distribution be improved by 
SAR steering?
Patients and Methods 
Patients 
Data used in this retrospective study were selected from 
our patients’ database. Selection criteria were: (1) intratu-
mor and intraluminal temperature measurements, (2) tumor 
location: pelvis, (3) tumor type: rectum, cervix, or bladder. 
Based on these criteria, 58 patients (143 treatments) were 
selected. 
Accessibility of temperature data, as registered by the 
BSD-2000 system, requires specific tools and it is subjected to 
failures as explained by Fatehi et al. [3]. For the present study, 
it was not possible to transfer the PDOS-formatted data of 
nine patients (16 treatments) to MSDOS. Additionally, dur-
ing the data processing by means of RHyThM (Rotterdam 
Hyperthermia Thermal Modulator), it was not possible to ac-
cess temperature data of one patient (2 treatments) and 25 
single treatments. 
With these limitations, 48 patients (100 treatments) were 
available for analysis. Patients were grouped in four catego-
ries: male rectal cancer (n = 21 patients, 39 treatments), fe-
male rectal cancer (n = 14 patients, 27 treatments), cervical 
cancer (n = 8 patients, 21 treatments), and bladder cancer 
(n = 5 patients, 13 treatments). For a detailed description of 
patient characteristics and tumor stage see van der Zee et 
al. [11]. 
Hyperthermia 
Hyperthermia was performed using the BSD-2000 with the 
Sigma-60 applicator (BSD Corporation, Salt Lake City, UT, 
USA) [10]. One to five (mean: four) locoregional hyperther-
mia treatments were delivered to the pelvis once weekly dur-
ing the period of radiotherapy or chemotherapy. Hyperther-
mia was started at 400 W RF power. The treatment settings for 
frequency, amplitude distribution, and phase shifting at the 
start of the first treatment were selected according to the local 
protocol. 
Patients were carefully instructed to mention any un-
pleasant sensation that might be the result of a hot spot [11]. 
Power output was increased to the patient’s tolerance with-
out pain. To improve the temperature distribution or to re-
lieve pain complaints, treatment settings were adapted, i.e., 
phase, power per channel, frequency, or by placing additional 
water boluses. Treatment duration was 60 min after any of 
the intratumor-measured temperatures had reached 42 °C, 
or to a maximum of 90 min. Water bolus temperature was 
maintained at 20 °C. Systemic temperature was controlled 
by cooling measures: undressing, air-conditioning, wet tow-
els, and ice packs. The bladder was kept empty with a Foley 
catheter [4]. 
Thermometry 
Intratumor catheter placement was planned at least 1 day 
prior to the first hyperthermia treatment. 5 F polyethylene 
closed-tip thermometry catheter(s) (William Cook Europe 
ApS, Bjaeverskov, Denmark) were introduced in the tumor 
transgluteally under CT control. For details see van der Zee et 
al. [11]. Intraluminal catheters were inserted in bladder, rec-
tum, and vagina lumen (as relevant) before each treatment. 
After catheter placement, the intratumor and intraluminal 
depths were documented. Insertion length of the intralumi-
nal catheters was measured manually using a standard caliper. 
Bowman probes [1] were used to assess real-time temperature 
reading (accuracy: ± 0.1 °C). Temperature mapping was per-
formed in 1 cm increments to a maximum length of 14 cm. 
Thermal mapping started just before the treatment and was 
repeated at 5-min intervals. 
Data Processing and Definitions 
The method of data processing has been extensively described 
by Fatehi et al. [3, 4]. In this study, the intratumor tempera-
ture is defined as temperature data acquired from within the 
tumor. The intraluminal temperatures are reported as normal 
tissue, tumor contact, tumor-indicative, or overall measure-
ments. Tumor contact means that the catheter at the site of 
measurement lies in contact with tumor. When the site of 
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measurement is in the same transverse plane as the tumor, but 
not in contact with the tumor, the temperature is called tu-
mor-indicative [13]. The remaining measurements represent 
normal tissue. The overall intraluminal temperature includes 
all measurements within one catheter; all lumina temperature 
includes all measurements within all intraluminal catheters, 
and the related lumen temperature refers to rectum lumen 
temperature for rectal cancer, to vagina lumen temperature 
for cervix cancer, and to bladder lumen temperature for blad-
der cancer patients.
Statistical Analysis
The statistical analysis was based on the temperature dose pa-
rameters, as provided in the ASCII files by RHyThM. Tem-
perature measurements were available per patient, per treat-
ment session, per probe, per mapping position, and per time 
point. All temperature measurements < 37 °C were excluded. 
The time points were scaled with respect to the starting time 
of the treatment. While computing averages, all observations 
were weighted equally.
The thermal dose parameters calculated per patient per 
treatment session were: average temperature (Tmean), T10, and 
T90 (TX means the temperature which is exceeded by X per-
cent of all temperature readings). The averages and standard 
deviations were computed for all thermal dose parameters of 
different lumina (bladder, vagina, and rectum) and different 
tissue types (normal tissue, tumor indicative, tumor contact, 
and intratumor). Averages of intratumor and intraluminal 
temperatures were compared with t-tests. The p-values are 
two-sided at a significance level of α = 0.05. STATA (version 
9.2) was used for the statistical analysis.
Results 
Intratumor Versus Intraluminal Temperatures 
Temperature indices were calculated per patient, per treat-
ment session and per time point from start until end of the 
treatment. Per patient per treatment, correlation coeffi-
cients were computed between intratumor and intraluminal 
tumor-indicative/tumor contact temperatures and between
intratumor and intraluminal normal/all tissues tempera-
tures. Averages of correlation coefficients between intratu-
mor and intraluminal temperatures are presented in Table 1, 
and their relations are graphically summarized per treat-
ment in Figure 1. Strong correlation was found between in-
tratumor and intraluminal tumor contact/tumor-indicative 
temperatures in the four patient groups (average correla-
tion coefficients vary from 0.91 to 0.96). In addition, good 
to strong correlation existed between intratumor and in-
traluminal normal/all tissues temperatures in the four pa-
tient groups (average correlation coefficients vary from 0.74 
to 0.96). 
Quantitative/Qualitative Temperature Analysis 
For each group of patients, temperature indices were calculat-
ed per relevant tissue or relevant lumen and per time interval 
of 5 min. For each group of patients, a graph has been made 
which shows the relation between time and average tempera-
ture per relevant tissue or relevant lumen (Figure 2). An over-
view of average temperature indices in the four patient groups 
is given in Table 2.
In the male rectal cancer group (Figure 2a), the aver-
age intratumor Tmean (40.3 ± 0.7 °C) was slightly lower than 
the averages of intraluminal rectum tumor indicative Tmean 
Table 1. Slopes and correlation coefficients between averages of intratumor and intraluminal temperatures in the four patient groups as obtained 
in the study. Numbers in parentheses show 1 SD (standard deviation). 
Tabelle 1. Steigungen und Korrelationskoeffizienten zwischen durchschnittlichen intratumoralen und intraluminalen Temperaturen in den vier 
Patientengruppen, wie in der Studie erreicht. Die Zahlen in Klammern zeigen 1 SD (Standardabweichung). 
           Intratumor vs. intraluminal Intratumor vs.  Intratumor vs. overall
 tumor contacta/tumor- intraluminal normal intraluminal temperatures
 indicative temperatures tissue temperatures in the related lumenb 
 Slopec Correlation Slopec Correlation  Slopec Correlation
  coefficient  coefficient  coefficient
  (1 SD)  (1 SD)  (1 SD) 
Rectal cancer male
(17 patient, 27 treatments) 0.80 (0.23) 0.95 (0.03) 0.61 (0.25) 0.81 (0.25) 0.70 (0.27) 0.80 (0.32)
Rectal cancer female
(13 patients, 25 treatments) 0.84 (0.37) 0.95 (0.05) 0.77 (0.41) 0.85 (0.25) 0.74 (0.37) 0.88 (0.20)
Cervical cancer
(6 patients, 18 treaments) 0.90 (0.67) 0.96 (0.03) 0.78 (0.27) 0.90 (0.16) 0.86 (0.44) 0.96 (0.04)
Bladder cancer
(5 patients, 12 treatments) 0.84 (0.26) 0.91 (0.07) 0.66 (0.31) 0.74 (0.35) 0.76 (0.34) 0.79 (0.31)
aTumor contact is used for the cervical cancer patients and tumor indicative for the rectal cancer patients. In the bladder cancer patients, the numbers are average for tumor 
contact and tumor indicative; bRelated lumen temperature refers to rectum lumen temperature for rectal cancer patients, to vagina lumen temperature for cervix cancer patients, 
and to bladder lumen temperature for bladder cancer patients; cThe analysis was based on Y = aX and “a” represents the slope. Slope < 1 means that intratumor temperature 
increases slower than intraluminal temperature and vice versa for slope > 1 
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(∆T = 0.2 °C), rectum overall Tmean (∆T = 0.2 °C), 
and all lumina Tmean (∆T = 0.1 °C).
In the female rectal cancer patients (Figure 
2b), the average intratumor Tmean (40.4 ± 0.8 °C) 
was lower than the averages of intraluminal rec-
tum tumor-indicative Tmean (∆T = 1.1 °C), rectum 
overall Tmean (∆T = 0.6 °C), and all lumina Tmean 
(∆T = 0.2 °C). 
In the cervix cancer group (Figure 2c), the 
average intratumor Tmean (39.4 ± 0.9 °C) was 
slightly lower than the averages of intraluminal 
vagina tumor contact Tmean (∆T = 0.2 °C), vagina 
overall Tmean (∆T = 0.5 °C), and all lumina Tmean 
(∆T = 0.6 °C). 
In the bladder cancer patients (Figure 2d), 
the average intratumor Tmean (40.9 ± 1.1 °C) was 
slightly higher than the averages of intraluminal 
bladder tumor-indicative Tmean (∆T = 0.2 °C), 
bladder overall Tmean (∆T = 0.6 °C), and all lumina 
Tmean (∆T = 0.4 °C). 
No significant difference was found between 
the intratumor and intraluminal temperatures in 
the four patient groups. Overall, the temperature 
measurements data were lowest in the cervical 
cancer patient group. 
Intratumor Temperature Distributions 
Temperature-time profiles per mapping position 
were computed for intratumor temperatures in 
each single treatment (Figure 3). We hypothesized 
that if SAR steering is effective in improving tu-
mor temperature homogeneity, then the tempera-
ture time curves of a single treatment should show 
a homogeneous and preferable high temperature 
distribution. However, a clear improvement of 
temperature distribution was not seen in 26/27 
treatments (96%) of male rectal cancers, and in 
25/25 treatments (100%) of female rectal cancers. 
This was also the case for 94% (17/18 treatments) 
of cervical cancers, and 92% (11/12 treatments) of 
bladder cancers. The 18 remaining treatments had 
no more than one intratumor temperature point 
available for analysis. 
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Figurs 1a to 1c. Intratumor temperatures versus intralu-
minal rectum overall temperatures in rectum cancers (a), 
vagina overall temperatures in cervix cancers (b), and 
bladder overall temperatures in bladder cancers (c). 
Abbildungen 1a bis 1c. Intratumorale Temperaturen ver-
sus intraluminale rektale Gesamttemperaturen bei Rek-
tumkarzinomen (a), vaginale Gesamttemperaturen bei 
Gebärmutterhalskarzinomen (b) und vesikale Gesamt-
temperaturen bei Blasenkarzinomen (c). 
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Discussion 
Interstitial thermometry during locoregional hyperthermia 
is done for two main reasons: first, to apply the best pos-
sible treatment to the individual patient, by monitoring the 
achieved temperature level in a large tumor volume; second, 
for answering questions of more scientific nature, such as 
which equipment performs better in certain conditions, or 
which temperature increase pattern or thermal dose gives the 
highest probability of a good treatment result. In this study, 
we have focused on the question whether intraluminal tem-
perature measurements provide sufficient information to ap-
ply hyperthermia at the maximum achievable level. 
This study shows 
(1)  the temperatures achieved with the BSD-2000 in intrapel-
vic tumors are generally between 39.5 and 42 °C.
(2)  there is a high correlation between temperatures measured 
intratumorally and intraluminally. 
(3)  the intratumor and intraluminal temperature-time pro-
files follow similar patterns. The later two findings mean 
that intraluminal temperatures can be used to monitor the 
change of intratumor temperatures. 
(4)  in 96% of treatments the intratumor temperature distribu-
tion pattern remains the same during 90 min of heating, in 
spite of SAR steering adjustments meant to improve the 
temperature distribution. This means the temperature dis-
tribution is insensitive to current SAR steering procedures. 
This is not a surprising result, since the used frequency of 
70 MHz does not allow small-scale SAR steering. 
There were five treatments where we found a poor correlation 
(< 0.7) between intratumor and intraluminal temperatures 
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(Figure 1). For four treatments, we found a clear explanation 
for the discrepancy. In patients 410 (treatment 1), 420 (treat-
ment 2) and 669 (treatments 1 and 2), the tumor was located 
excentrically near the iliac crest, so that the intraluminal tem-
peratures were measured far from the tumor. These findings 
show that for treatment of tumors outside the region where 
intraluminal thermometry is possible, intratumoral thermom-
etry is the only way to get information on treatment quality. 
Patient 447 (treatment 1) had the rectal ampulla filled with 
feces during the first treatment, which may explain the much 
higher rectal temperatures compared to intratumor tempera-
tures. 
These results confirm the clinical impression that intra-
tumor thermometry does not add to the quality of treatment 
when the BSD-2000 system is used for treatment of intrapelvic 
centrally located tumors, and that intraluminal temperature 
measurements are sufficient to apply the best possible treat-
ment to the individual patient [11]. Wust et al. came to the 
same conclusion, based on an analysis of relations between 
intraluminal and intratumoral SAR measurements in patients 
with cervical and rectal cancer [16]. Elsewhere, Hoffmann et 
al. [5] reported rectal temperatures with MRI like those found 
in the present study. Likewise, Wust et al. [15] and Sreenivasa 
et al. [8] recently found that intraluminal temperatures are re-
lated to the response probability. There are no reasons to as-
sume that this result will be different for other equipment us-
ing radiative electromagnetic heating at frequencies between 
70 and 120 MHz and SAR control by phase and amplitude 
steering. 
Whether it is justified to use intraluminal thermometry 
only during treatment of intrapelvic tumors appears a matter 
of institute’s priorities. We agree with Sneed et al. who state 
that the only way to calculate tumor thermal dose is to mea-
sure the tumor temperature directly [7]. Intraluminal ther-
mometry reflects, but is not equal to intratumor thermometry. 
However, whether this is important depends on the aim of the 
measurements, especially taking the disadvantages of intratu-
mor thermometry into account: time consuming, stressful and 
Table 2. Average of various temperature values (in °C) for the four patient groups. Numbers in parentheses show 1 SD (standard deviation).
Tabelle 2. Durchschnitt verschiedener Temperaturwerte (in °C) für die vier Patientengruppen. Die Zahlen in Klammern zeigen 1 SD (Standardab-
weichung).
  Rectum cancer (males) Rectum cancer (females) Cervix cancer  Bladder cancer
  (21 patients, 39 treatments) (14 patient, 27 treatments) (8 patients, 21 treatments) (5 patients, 13 treatments)
  T90
a Tmean T10 T90 Tmean T10 T90 Tmean T10 T90 Tmean T10
Tumor Intratumor  39.4  40.3  41.2  39.5  40.4  41.3  38.3  39.4  40.0  39.9  40.9  41.8
 temperature (0.7) (0.7) (1.1) (0.8) (0.8) (1.1) (1.0) (0.9) (1.0) (1.0) (1.1) (1.2)
 Normal  39.3 40.2 41.0 39.7 40.3 41.0 39.4 40.3 41.1 39.1 39.8 40.5
 tissue (1.5) (1.2) (1.1) (0.6) (0.5) (0.6) (0.9) (0.7) (0.7) (1.1) (1.2) (1.3)
 Tumor – – – – – – – – – 39.3  40.4 41.4
 contact          (1.0) (1.0) (0.9)
 Tumor-  39.6 40.2) 40.9 39.8 40.4 41.0 39.3 40.1 40.8 39.5 40.7 41.7
 indicative  (0.7) (0.5) (0.6) (1.1) (0.9) (1.0) (0.8) (0.6) (0.8) (1.5) (1.3) (1.2)
 Overall 39.5 40.2 41.0 39.8 40.4 41.0 39.4 40.2 41.0 39.3 40.3 41.2  
  (1.1) (0.9) (0.9) (0.9) (0.7) (0.8) (0.9) (0.7) (0.8) (1.2) (1.2) (1.1)
 Normal – – – 39.6 40.3 41.1 39.4 40.1 40.9 40.0 40.7 41.3
 tissue    (1.2) (1.0) (0.8) (1.1) (1.0) (0.9) (1.3) (1.1) (0.8) 
 Tumor – – – 39.7  40.4 41.0) 38.9 39.6 40.3 39.7 40.5 41.4
 contact    (1.5) (1.1) (1.0) (0.9) (0.9) (1.0) (1.1) (0.9)  (0.7)
 
Overall
 – – – 39.7 40.4 41.1 39.2 39.9 40.6 39.9 40.6 41.4
     (1.4) (1.1) (0.9) (1.0) (1.0) (0.1) (1.2) (1.0) (0.8)
 Normal  39.8 40.5 41.1 39.6 40.5 41.4 39.2 40.0 40.9 39.8 40.4 41.0
 tissue (1.0) (1.0) (1.0) (1.3) (1.4) (1.6) (0.8) (0.7) (0.7) (1.0) (0.9) (0.9)
 Tumor-  39.7 40.5 41.3 40.8 41.5 42.2 39.2 39.9 40.4 39.9 40.5 41.1
 indicative (1.0) (0.8) (0.7) (1.1) (1.4) (1.6) (0.8) (0.8) (1.0) (0.4) (0.4) (0.4)
 
Overall
 39.8 40.5 41.2 40.2 41.0 41.8 39.2 40.0 40.7 39.9 40.5 41.1
  (1.0) (0.9) (0.9) (1.2) (1.4) (1.6) (0.8) (0.8) (0.9) (0.7) (0.7) (0.7)
All  Intraluminal  39.6 40.4 41.1 39.9 40.6 41.3 39.2 40.0 40.7 39.7 40.5 41.2
lumina temperature (1.1) (0.9) (0.9) (1.1) (1.1) (1.1) (0.9) (0.8) (0.9) (1.0) (0.9) (0.8)
a TX means the temperature which is exceeded by X percent of all temperature readings 
Bladder
lumen
Vagina
lumen
Rectum
lumen
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painful to the patient, and severe side effects (bleeding, infec-
tion, tumor seeding, etc.). We find thermometry important for 
the application of hyperthermia at the maximum achievable 
temperature levels. For this aim, intraluminal thermometry is 
sufficient. In our experience, intratumor thermometry was the 
major cause of treatment related toxicity [11]. Introduction of 
thermometry catheters before each separate treatment session 
may decrease the complication rate, but it remains an unpleas-
ant, time consuming and costly procedure. The results of the 
detailed temperature analysis presented here and the latest 
publication of Wust et al. [15] and Sreenivasa et al. [8] support 
our earlier decision to abandon intratumor thermometry. Of 
course, this discussion becomes redundant when noninvasive 
thermometry is widely available [12]. 
Conclusion 
The high correlations between intraluminal and intratumor 
temperatures and the current lack of possibilities to improve 
intratumor temperature distribution by SAR steering justify 
to guide deep regional hyperthermia application to centrally 
located tumors in the lesser pelvis with intraluminal thermom-
etry only. 
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